FDA Approves ChemoCentryx’s Tavenos October 8, 2021 Auto Bot News 0 The approval of ChemoCentryx’s Tavenos (avacopan) provides a new treatment for active anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
